http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3652340-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_23622899a40ed163cd5bf570d6baf2a3 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6809 |
| filingDate | 2018-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79485adb1e817b28844e86610a5f9da6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5976309c9ecd44ecd7ef7e59a3b6c1d |
| publicationDate | 2020-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-3652340-A1 |
| titleOfInvention | Microrna-455-3p as a peripheral biomarker for alzheimer's disease |
| abstract | The present invention includes a method of identifying a patient suffering from Alzheimer's disease (AD) prior to attaining a clinical classification of the disease, comprising: obtaining a data set associated with a blood sample patient's serum or plasma, the data set comprising data representing the level of one or more microRNA biomarkers in the blood, serum or plasma sample; Evaluating the dataset for the presence or increase of miRNA-455-3p; to determine the likelihood of the patient developing AD before clinically classifying the disease by detecting the presence or increase of miRNA-455-3 p to produce a score indicative of a probability of developing the AD, a score higher than that of a healthy control indicating that the patient is likely to present the prognosis of a transition to a classified AD, the healthy control being derived from a patient not suffering from AD and not presenting clinical evidence of AD. |
| priorityDate | 2017-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 452.